
Anker's Dual SD and MicroSD Card Reader Drops Below $10, It Feels Like a Giveaway
See at Amazon
The Anker SD card reader has two slots built-in. We get one for a standard SD card and one for MicroSD. It's universal in its compatibility. The SD slot works with SDHC, RS-MMC, SD cards, and MMC Micro. Just next to it, the MicroSD slot works with microSDXC, microSDHC, and microSD. The unit is super compact, only about the same size as any old USB flash drive.
The card reader can connect to your laptop over USB-C. Kind of remarkable, it can also connect to newer phones or tablets that use USB-C. So you can move photos or videos to and from your phone if you have a need to. The design is phone case friendly with its optimized connector and body shape. It's always a minor inconvenience to need to remove your phone case when wanting to use it with something so it's nice to see that's not an issue here with the Anker card reader.
It's plug and play meaning you can hot swap cards as you need to immediately access any of your stored data. Data can transfer crazy fast at 5Gbps. You can sync a picture album or library of music is just seconds.
Anker is a huge brand when it comes to any thing and everything consumer tech. Its carved a name for itself with its chargers, power banks, and other accessories. You can expect the same reliability here with its SD card reader. And right now, you can get it for pretty much next to nothing. Amazon normally lists the Anker SD and MicroSD dual-card reader for $18. After the 50% discount, you'll be getting it for just $9.
See at Amazon

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Merck & Co., Inc. (MRK) Impresses Jim Cramer With Its Toughness
We recently published . Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer recently discussed. Merck & Co., Inc. (NYSE:MRK)'s shares have lost 16% year-to-date as investors continue to be disappointed by the dropping revenue of its GARDASIL HPV drug in China. They are also worried about the patent expiration of the firm's mega cancer drug KEYTRUDA and wondering whether Merck & Co., Inc. (NYSE:MRK) will be able to follow up with an equally successful successor. However, the shares did gain 3% this week after Pfizer announced that its bladder cancer drug PADCEV improves survival rates when paired with KEYTRUDA. Cramer was impressed as he commented: 'Look at Merck. I mean, Saint Merck. What a tough, what a tough.' Photo by National Cancer Institute on Unsplash Here are his earlier comments about Merck & Co., Inc. (NYSE:MRK): 'Well, this GARDASIL, when is it? The Chinese are not really helping them sell, because you would have thought the Chinese would. . .and then you've got the KEYTRUDA, you know the patent cliff coming up. . .it's amazing, but they are talking about their animal division. When you're talking about your animal division you don't have enough [inaudible] to talk.' While we acknowledge the potential of MRK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
17 minutes ago
- Yahoo
Salesforce, Inc. (CRM)'s CEO Is Pushing Back Against The AI Vs Enterprise Software Narrative, Says Jim Cramer
We recently published . Salesforce, Inc. (NYSE:CRM) is one of the stocks Jim Cramer recently discussed. Salesforce, Inc. (NYSE:CRM)'s shares have lost 28% year-to-date as the firm has struggled to retain investor attention in the age of AI. Like investors are hawkishly watching its revenue pipeline and revenue commitments for the rest of the year – a fact which led the stock to dip 5% in May after its fiscal first quarter earnings. Cramer discussed the sentiment surrounding enterprise software stocks and CEO Marc Benioff's attempts to counter it: '. . .and I think that people should recognize that these companies are all being viewed as, let's say carrion, because what's happened is this that you can develop your own stuff that is better. Now Marc Benioff is doing some pushback on that by the way, he's saying that if you're doing process stuff, you're not going to be able to, maybe creative, that would be Adobe. But not, Salesforce. So Marc's pushing back Salesforce. . .' Pixabay/Public Domain Here are his previous remarks about Salesforce, Inc. (NYSE:CRM): 'Okay, so Salesforce is a little tough right now because right now, the enterprise software companies are all coming down. I have not been recommending the stock hard. I want to see what happens with the quarter. I wish I could be more definite, but sometimes it's better just to say I don't have a handle on it.' While we acknowledge the potential of CRM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
17 minutes ago
- Yahoo
Intel Corporation (INTC): They Have To Fix The Balance Sheet, Says Jim Cramer
We recently published . Intel Corporation (NASDAQ:INTC) is one of the stocks Jim Cramer recently discussed. Intel Corporation (NASDAQ:INTC)'s shares have stabilized this week after CEO Lip-Bu Tan met with President Trump to assure him of his loyalty to America. Trump had demanded last week that Tan leave his role as Intel Corporation (NASDAQ:INTC)'s CEO due to his ties with Chinese companies. Cramer commented on the developments and on reports of disagreements within the firm's board: Thank you for bringing that [story about differences in Intel's board] up because I was going to go over that story, now I don't have to. But it's totally overblown. Pixabay/Public Domain 'Don't you think it's interesting that Gelsinger was one of the presenters for Lip-Bu Tan when he won the 2022 Noyce Award. And then, what happened? He resigned from the board, remember in protest to Gelsinger's stuff, Lip-Bu Tan. And now he's running it. And news outlets have the story that there's dissension? When I can't find a single dissenter? I can't! While we acknowledge the potential of INTC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.